GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.35
Bid: 6.35
Ask: 7.05
Change: -0.475 (-6.96%)
Spread: 0.70 (11.024%)
Open: 6.30
High: 6.35
Low: 6.30
Prev. Close: 6.825
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Brazil approves PHC279 to Control Soybean Rust

5 Jan 2021 15:37

RNS Number : 6638K
Plant Health Care PLC
05 January 2021
 

RNS

5 January 2021

 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

Brazil approves PHC279 to Control Asian Soybean Rust: First Product from PREtec Platform Approved for Sale in Brazil

Plant Health Care® (AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce its new seed treatment, PHC279, for the prevention and treatment of Asian soybean rust (ASR) has received federal approval for sale in Brazil.

Highlights

· PHC279 is the first product from Plant Health Care's PREtec technology platform ("Vaccines for Plants") approved for sale in Brazil, following $20m invested globally over the last eight years.

· PHC279 has the potential to deliver disease control and yield increase worth approximately US$75/ha for Brazilian soybean growers, giving them an ROI of 6x or more, while reducing the use of potentially less safe agrochemicals.

· PHC279's environmentally friendly profile and unique mode of action is expected to lead to wide adoption by Brazilian soybean growers.

· The Company aims to launch PHC279 during the second half of 2021 and expects to build significant market penetration over the following 2-3 years; gross margins are expected to be comparable to those of current Harpin products.

· PREtec peptides represent a novel class of technology which stimulate the plant to defend itself. Derived from natural proteins, PREtec is an environmentally friendly approach to protecting crops and is compatible with mainstream agricultural practices.

· Brazil is the world's leading soybean producer with 38.6 million hectares (95.3 million acres) planted in the current season. ASR, caused by the fungus Phakopsora pachyrhizi, is a devastating disease with an estimated crop yield loss of up to 90%. Brazilian soybean farmers spent US$2 billion on fungicides during the 2016/2017 harvest for ASR control. Intensive use of traditional chemical fungicides has resulted in the reduction of efficacy of those products over time, highlighting the need for new, environmentally friendly products such as PHC279.

The regulatory process in Brazil for agricultural products involves detailed review and approval by three government agencies. The Ministry of Agriculture (MAPA) confirms that a product is effective; the National Health Surveillance Agency (ANVISA) checks for safety to humans in use and in food, while the Brazilian Institute of Environment and Renewable Natural Resources (IBAMA) confirms that products do not pose a threat to the environment. While the time required for registration of conventional pesticides can be six years or more, PHC279 passed through this process with approval from all three agencies in one year. This confirms the Brazilian government's commitment to promoting effective and environmentally friendly products.

Chris Richards, CEO of Plant Health Care said, "PHC279 is the first of many products we plan to introduce in Brazil from the Company's PREtec platform. Achieving regulatory approval in Brazil in under 12 months is a strong endorsement of the sustainability credentials of PHC279. We anticipate launching PHC279 for use in the 2021/22 soybean season and the Company is advancing plans to secure distribution partners. Outside Brazil, we are preparing to launch this novel technology directly to markets in the U.S. and other countries, initially targeting markets with an opportunity of $5 billion."

For further information, please contact:

Plant Health Care plc

Chris Richards, CEO, Tel: +1 919 926 1600

 

Arden Partners plc - Nomad & Broker

John Llewellyn-Lloyd / Ben Cryer Tel: +44 (0) 20 7614 5900

 

Company website: www.planthealthcare.com

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REASSDFIIEFSEDF
Date   Source Headline
1st Apr 20093:40 pmRNSAdditional Listing
30th Mar 20097:00 amRNSDirector/PDMR Shareholding
24th Mar 200910:49 amRNSChange of Registered Office
24th Mar 20097:00 amRNSFinal Results
2nd Mar 200910:06 amRNSTotal Voting Rights
2nd Feb 200912:53 pmRNSTotal Voting Rights
2nd Feb 200911:01 amRNSBoard Appointment
28th Jan 20094:36 pmRNSPrice Monitoring Extension
28th Jan 20097:00 amRNSAdditional Listing
22nd Jan 20097:00 amRNSTrading Statement
15th Jan 20097:00 amRNSNew Appointments
5th Jan 20099:57 amRNSSignificant Shareholding
31st Dec 200811:19 amRNSTotal Voting Rights
19th Dec 20084:22 pmRNSHolding(s) in Company
18th Dec 20087:01 amRNSFurther re Myconate
18th Dec 20087:00 amRNSTermination of Agreement
16th Dec 20087:00 amRNSFinal Agreement with Monsanto
1st Dec 200810:02 amRNSTotal Voting Rights
26th Nov 20087:00 amRNSField Trials
18th Nov 200812:21 pmRNSAdditional Listing
31st Oct 20083:35 pmRNSTotal Voting Rights
30th Oct 20084:01 pmRNSBoard Appointment
20th Oct 200811:26 amRNSHolding(s) in Company
8th Oct 20081:05 pmRNSSignificant shareholding
2nd Oct 20087:52 amRNSField Trials
30th Sep 20088:00 amRNSTotal Voting Rights
25th Sep 20087:00 amRNSRe Scotts agreement
23rd Sep 20087:00 amRNSPreTect Field Trial Results
17th Sep 20087:00 amRNSAgreement with Bayer CropScience
15th Sep 20082:06 pmRNSPosting of Interim Results
9th Sep 20084:32 pmRNSDirector/PDMR Shareholding
8th Sep 20087:01 amRNSSupply Agreement
8th Sep 20087:00 amRNSInterim Results
1st Sep 200810:03 amRNSTotal Voting Rights
29th Aug 200810:37 amRNSNotice of Results
15th Aug 200812:36 pmRNSHolding(s) in Company
1st Aug 20081:08 pmRNSTotal Voting Rights
7th Jul 200812:21 pmRNSHolding(s) in Company
4th Jul 20087:00 amRNSProduct Update
3rd Jul 20087:00 amRNSCleantech Index
2nd Jul 200812:07 pmRNSStock Award
1st Jul 200811:49 amRNSTotal Voting Rights
17th Jun 20085:36 pmRNSAdditional Listing
17th Jun 20083:47 pmRNSNotification of Shareholding
13th Jun 20082:07 pmRNSHolding(s) in Company
12th Jun 20087:00 amRNSField Trials
6th Jun 200812:59 pmRNSResult of Annual General Meet
6th Jun 20087:00 amRNSAGM Statement and Trading Upd
3rd Jun 20087:30 amRNSField Trials
2nd Jun 20089:50 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.